The present invention relates to novel antiviral active components of general formula 1, a pharmaceutical composition, an antiviral drug and a method for preventing and treating viral diseases, in particular diseases caused by the hepatitis C virus (HCV). In general formula 1, R1 is a hydrogen atom, optionally substituted C